Key Figures Q4 2020
SEK m, unless otherwise stated |
2020 Oct-Dec |
2019 Oct-Dec |
2020 Jan-Dec |
2019 Jan-Dec |
2019-2020 Oct-Dec Δ |
Net revenues |
159.2 |
238.1 |
663.6 |
844.8 |
-33% |
Cost of goods sold |
-11.3 |
-23.0 |
-65.6 |
-105.6 |
-51% |
Operating expenses |
-158.9 |
-143.5 |
-617.9 |
-508.8 |
11% |
EBIT |
-11.0 |
71.5 |
-19.9 |
231.2 |
-115% |
EBIT margin, % |
-6.9 |
30.0 |
-3.0 |
27.4 |
-36.9 ppt |
EBITDA |
1.0 |
85.8 |
19.0 |
272.1 |
-99% |
Earnings per share, before dilution, SEK |
-1.45 |
1.12 |
-2.45 |
6.33 |
-230% |
Earnings per share, after dilution, SEK |
-1.45 |
1.10 |
-2.45 |
6.20 |
-232% |
Cash flow from operating activities |
-11.2 |
60.2 |
16.8 |
287.0 |
-119% |
Cash and cash equivalents |
505.3 |
816.8 |
505.3 |
816.8 |
-38% |
Net revenues and EBIT per segment Q4 2020
SEK m |
Revenues |
EBIT |
||||||
|
2020 Oct-Dec |
2019 Oct-Dec |
2020 Jan-Dec |
2019 Jan-Dec |
2020 Oct-Dec |
2019 Oct-Dec |
2020 Jan-Dec |
2019 Jan-Dec |
ZUBSOLV® US |
143.1 |
190.5 |
623.3 |
719.2 |
- |
- |
- |
- |
US Pharma – total |
143.1 |
190.5 |
623.3 |
719.2 |
94.4 |
95.5 |
331.2 |
347.1 |
Digital Therapeutics (DTx) product sales |
0.0 |
- |
0.0 |
- |
- |
- |
- |
- |
Digital Therapeutics (DTx) – total |
0.0 |
- |
0.0 |
- |
-65.3 |
0.9 |
-175.4 |
-0.9 |
Abstral® royalties |
15.1 |
46.2 |
29.7 |
112.6 |
- |
- |
- |
- |
Edluar® royalties |
0.9 |
1.3 |
10.4 |
11.6 |
- |
- |
- |
- |
ZUBSOLV® - ex US |
- |
- |
0.1 |
0.1 |
- |
- |
- |
- |
OX-MPI |
- |
0.0 |
- |
1.4 |
- |
- |
- |
- |
HQ & Pipeline segment – total |
16.0 |
47.5 |
40.2 |
125.6 |
-40.1 |
-23.2 |
-175.8 |
-115.0 |
Total |
159.2 |
238.1 |
663.6 |
844.8 |
-11.0 |
71.5 |
-19.9 |
231.2 |
Cash flow Q4 2020
SEK m |
2020 Oct-Dec |
2019 Oct-Dec |
2020 Jan-Dec |
2019 Jan-Dec |
Cash flow from operating activities |
-11.2 |
60.2 |
16.8 |
287.0 |
Investment activities |
-29.0 |
-11.0 |
-189.2 |
-22.4 |
Financing activities |
-4.3 |
-4.3 |
-111.3 |
-53.7 |
Cash flow (excl exchange rate differences) |
-44.6 |
44.8 |
-283.7 |
210.8 |
Liquid funds |
505.3 |
816.8 |
505.3 |
816.8 |